These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 1442174)
1. A macrophage derived blastogenic factor -MBF- induces cytokines and cytotoxic effectors in human peripheral blood mononuclear cells. Ausiello CM; Antonelli G; Spagnoli GC; Gentile M; Urbani F; Gitto M J Biol Regul Homeost Agents; 1992; 6(1):8-14. PubMed ID: 1442174 [TBL] [Abstract][Full Text] [Related]
2. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Aste-Amezaga M; D'Andrea A; Kubin M; Trinchieri G Cell Immunol; 1994 Jul; 156(2):480-92. PubMed ID: 7912999 [TBL] [Abstract][Full Text] [Related]
3. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha. Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154 [TBL] [Abstract][Full Text] [Related]
4. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages. Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537 [TBL] [Abstract][Full Text] [Related]
5. An in vitro Shwartzman reaction-like response is augmented age-dependently in human peripheral blood mononuclear cells. Motegi A; Kinoshita M; Sato K; Shinomiya N; Ono S; Nonoyama S; Hiraide H; Seki S J Leukoc Biol; 2006 Mar; 79(3):463-72. PubMed ID: 16387840 [TBL] [Abstract][Full Text] [Related]
6. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target. Jiang H; Stewart CA; Fast DJ; Leu RW J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576 [TBL] [Abstract][Full Text] [Related]
7. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing. Wiebke EA; Custer MC; Rosenberg SA; Lotze MT J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373 [TBL] [Abstract][Full Text] [Related]
8. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity. Owen-Schaub LB; Gutterman JU; Grimm EA Cancer Res; 1988 Feb; 48(4):788-92. PubMed ID: 3257408 [TBL] [Abstract][Full Text] [Related]
9. Initial characterization of a lymphokine pathway for the immunologic induction of tumor necrosis factor-alpha release from human peripheral blood mononuclear cells. Kornbluth RS; Gregory SA; Edgington TS J Immunol; 1988 Sep; 141(6):2006-15. PubMed ID: 3139748 [TBL] [Abstract][Full Text] [Related]
10. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist. Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315 [TBL] [Abstract][Full Text] [Related]
11. On the relative roles of interleukin-2 and interleukin-10 in the generation of lymphokine-activated killer cell activity. Spagnoli GC; Juretic A; Schultz-Thater E; Dellabona P; Filgueira L; Hörig H; Zuber M; Garotta G; Heberer M Cell Immunol; 1993 Feb; 146(2):391-405. PubMed ID: 8174177 [TBL] [Abstract][Full Text] [Related]
12. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4. Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells. Son YI; Dallal RM; Mailliard RB; Egawa S; Jonak ZL; Lotze MT Cancer Res; 2001 Feb; 61(3):884-8. PubMed ID: 11221875 [TBL] [Abstract][Full Text] [Related]
14. TNF alpha enhancement of NK and LAK cell functions induced by high-dose IL-2 in human peripheral blood mononuclear cells from patients pretreated with alpha IFN + IL-2. Favrot M; Combaret V; Blay JY; Capdeville R; Zhou DC; Clapisson G; Chouaib S; Franks CR; Philip T Eur Cytokine Netw; 1990; 1(4):221-7. PubMed ID: 2104243 [TBL] [Abstract][Full Text] [Related]
15. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells. Gaddy J; Broxmeyer HE Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743 [TBL] [Abstract][Full Text] [Related]
16. Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake. Laso FJ; Lapeña P; Madruga JI; San Miguel JF; Orfao A; Iglesias MC; Alvarez-Mon M Alcohol Clin Exp Res; 1997 Oct; 21(7):1226-31. PubMed ID: 9347083 [TBL] [Abstract][Full Text] [Related]
17. Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells. Kedar E; Rezai AR; Giorgi JV; Gale RP; Champlin RE; Mitsuyasu RT; Fahey JL Nat Immun Cell Growth Regul; 1988; 7(1):13-30. PubMed ID: 2896298 [TBL] [Abstract][Full Text] [Related]
18. Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro. Iho S; Yamamoto T; Takahashi T; Yamamoto S J Immunol; 1999 Oct; 163(7):3642-52. PubMed ID: 10490958 [TBL] [Abstract][Full Text] [Related]
19. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts. Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628 [TBL] [Abstract][Full Text] [Related]